182 related articles for article (PubMed ID: 9841888)
21. Regulation of cytokine-induced neuron death by ovarian hormones: involvement of antiapoptotic protein expression and c-JUN N-terminal kinase-mediated proapoptotic signaling.
Koski CL; Hila S; Hoffman GE
Endocrinology; 2004 Jan; 145(1):95-103. PubMed ID: 14512437
[TBL] [Abstract][Full Text] [Related]
22. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL.
Wiesner DA; Kilkus JP; Gottschalk AR; Quintáns J; Dawson G
J Biol Chem; 1997 Apr; 272(15):9868-76. PubMed ID: 9092523
[TBL] [Abstract][Full Text] [Related]
23. Ceramide channels: destabilization by Bcl-xL and role in apoptosis.
Chang KT; Anishkin A; Patwardhan GA; Beverly LJ; Siskind LJ; Colombini M
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2374-84. PubMed ID: 26215742
[TBL] [Abstract][Full Text] [Related]
24. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
25. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
Petak I; Vernes R; Szucs KS; Anozie M; Izeradjene K; Douglas L; Tillman DM; Phillips DC; Houghton JA
Cell Death Differ; 2003 Jun; 10(6):729-39. PubMed ID: 12761581
[TBL] [Abstract][Full Text] [Related]
26. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation.
Lin CF; Chen CL; Chang WT; Jan MS; Hsu LJ; Wu RH; Fang YT; Tang MJ; Chang WC; Lin YS
J Biol Chem; 2005 Jun; 280(25):23758-65. PubMed ID: 15817479
[TBL] [Abstract][Full Text] [Related]
28. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
[TBL] [Abstract][Full Text] [Related]
29. P53 mediates ceramide-induced apoptosis in SKN-SH cells.
Kim SS; Chae HS; Bach JH; Lee MW; Kim KY; Lee WB; Jung YM; Bonventre JV; Suh YH
Oncogene; 2002 Mar; 21(13):2020-8. PubMed ID: 11960374
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
31. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression.
Otsuka M; Kato N; Taniguchi H; Yoshida H; Goto T; Shiratori Y; Omata M
Virology; 2002 Apr; 296(1):84-93. PubMed ID: 12036320
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
34. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
Wagenknecht B; Schulz JB; Gulbins E; Weller M
Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
[TBL] [Abstract][Full Text] [Related]
35. Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells.
Blanco-Colio LM; Justo P; Daehn I; Lorz C; Ortiz A; Egido J
Kidney Int; 2003 Jul; 64(1):181-91. PubMed ID: 12787408
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 interrupts the ceramide-mediated pathway of cell death.
Zhang J; Alter N; Reed JC; Borner C; Obeid LM; Hannun YA
Proc Natl Acad Sci U S A; 1996 May; 93(11):5325-8. PubMed ID: 8643573
[TBL] [Abstract][Full Text] [Related]
37. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
[TBL] [Abstract][Full Text] [Related]
38. Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells.
McDonnell MA; Wang D; Khan SM; Vander Heiden MG; Kelekar A
Cell Death Differ; 2003 Sep; 10(9):1005-15. PubMed ID: 12934075
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
40. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
Schmitt E; Cimoli G; Steyaert A; Bertrand R
Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
